RAMAT GAN, Israel--(BUSINESS WIRE)--Optimata Ltd. today announced that the Optimata Virtual Patient® (OVP) has been approved as a registered trademark by the US Patent & Trademark Office. The company also announced the launch of a new module to simulate and optimize targeted therapy agents.
